These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 7631404

  • 41. Successful treatment of platelet transfusion refractoriness: the use of platelet transfusions matched for both human leucocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized patients with leukaemia.
    Kekomäki S, Volin L, Koistinen P, Koivunen E, Koskimies S, Ruutu T, Timonen T, Kekomäki R.
    Eur J Haematol; 1998 Feb; 60(2):112-8. PubMed ID: 9508352
    [Abstract] [Full Text] [Related]

  • 42. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H, Bertrand G, Zitouni S, Djenouni A, Martageix C, Griffi F, Kaplan C, Ouelaa H.
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. A specific assay for anti-HLA antibodies: application to platelet donor selection.
    Millard FE, Tani P, McMillan R.
    Blood; 1987 Nov; 70(5):1495-9. PubMed ID: 3311206
    [Abstract] [Full Text] [Related]

  • 45. [Refractory effect and alloimmunization after transfusion of thrombocytes].
    Volkova RI, Agranenko VA.
    Gematol Transfuziol; 1992 Feb; 37(2):16-21. PubMed ID: 1426903
    [Abstract] [Full Text] [Related]

  • 46. Alloimmune refractoriness to platelet transfusions.
    Sandler SG.
    Curr Opin Hematol; 1997 Nov; 4(6):470-3. PubMed ID: 9359008
    [Abstract] [Full Text] [Related]

  • 47. Predictive value of enzyme-linked immunoassay platelet crossmatching for transfusion of platelet concentrates to alloimmunized recipients.
    Brubaker DB, Duke JC, Romine M.
    Am J Hematol; 1987 Apr; 24(4):375-87. PubMed ID: 3551590
    [Abstract] [Full Text] [Related]

  • 48. C1q-binding anti-HLA antibodies do not predict platelet transfusion failure in Trial to Reduce Alloimmunization to Platelets study participants.
    Jackman RP, Lee JH, Pei R, Bolgiano D, Lebedeva M, Slichter SJ, Norris PJ.
    Transfusion; 2016 Jun; 56(6):1442-50. PubMed ID: 27079754
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients.
    Taaning E, Simonsen AC, Hjelms E, Svejgaard A, Morling N.
    Vox Sang; 1997 Jun; 72(4):238-41. PubMed ID: 9228715
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Clinical aspects of platelet transfusions.
    Murphy MF, Waters AH.
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
    [Abstract] [Full Text] [Related]

  • 53. Refractoriness to platelet transfusions in children with acute leukemia.
    DeCoteau J, Haddad S, Blanchette V, Poon A.
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):306-10. PubMed ID: 7583385
    [Abstract] [Full Text] [Related]

  • 54. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
    Jia Y, Li W, Liu N, Zhang K, Gong Z, Li D, Wang L, Wang D, Jing Y, Wang J, Shan X.
    Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Platelet refractoriness and alloimmunization.
    Slichter SJ.
    Leukemia; 1998 Sep; 12 Suppl 1():S51-3. PubMed ID: 9777897
    [Abstract] [Full Text] [Related]

  • 58. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice.
    Poston JN, Jash A, Hannan LM, Hay AM, Usaneerungrueng C, Howie HL, Kapp LM, Zimring JC.
    Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.